Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Boehringer Ingelheim
Harvard Business School
US Army
Farmers Insurance

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020226

« Back to Dashboard
NDA 020226 describes NAPHCON-A, which is a drug marketed by Alcon and is included in one NDA. It is available from one supplier. Additional details are available on the NAPHCON-A profile page.

The generic ingredient in NAPHCON-A is naphazoline hydrochloride; pheniramine maleate. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.

Summary for NDA: 020226

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020226

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC 020226 NDA Alcon Laboratories, Inc. 0065-0085 0065-0085-15 1 BOTTLE in 1 CARTON (0065-0085-15) > 15 mL in 1 BOTTLE
naphazoline hydrochloride; pheniramine maleate
SOLUTION/DROPS;OPHTHALMIC 020226 NDA Alcon Laboratories, Inc. 0065-0085 0065-0085-38 1 BOTTLE in 1 CARTON (0065-0085-38) > 30 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION/DROPS;OPHTHALMICStrength0.025%;0.3%
Approval Date:Jun 8, 1994TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Farmers Insurance
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus